Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2006-04-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2006.02.094PMID 16516853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo.

  2005cited by this paper
• Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients

  2005cited by this paper
• Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

  2005cited by this paper
• Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

  2005cited by this paper
• Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

  2005cited by this paper
• Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivo

  2005cited by this paper
• Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells

  2005cited by this paper
• Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo.

  2005cited by this paper
• 2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo

  2004cited by this paper
• Dynamic Balancing of the Dual Nature of HIF-1alpha for Cell Survival

  2004cited by this paper
• HIF‐1α induces cell cycle arrest by functionally counteracting Myc

  2004cited by this paper
• HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

  2004cited by this paper
• Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.

  2004cited by this paper
• Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α

  2004cited by this paper
• Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.

  2004cited by this paper
• Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.

  2003cited by this paper
• RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation.

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

  2003cited by this paper
• The hypoxic response of tumors is dependent on their microenvironment.

  2003cited by this paper
• Positron emission tomography scanning: current and future applications.

  2002cited by this paper
• Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

  2002cited by this paper
• Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells

  2001cited by this paper
• Levels of Hypoxia-Inducible Factor-1α During Breast Carcinogenesis

  2001cited by this paper
• Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

  2001cited by this paper
• Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy

  2001cited by this paper
• Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.

  2001cited by this paper
• A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector.

  2001cited by this paper
• Loss of PTEN facilitates HIF-1-mediated gene expression.

  2000cited by this paper
• Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

  2000cited by this paper
• Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

  2000cited by this paper
• Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth

  2000cited by this paper
• HIF-1 and human disease: one highly involved factor.

  2000cited by this paper
• The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

  1999cited by this paper
• Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.

  1999cited by this paper
• Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

  1998cited by this paper
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• A novel method for real time quantitative RT-PCR.

  1996cited by this paper
• Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

  1995cited by this paper

• Hepatocyte nuclear factor 4, alpha (HNF4A): A potential biomarker for chronic hypoxia in MCF7 breast cancer cell lines

  2025cites this paper
• Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance.

  2025cites this paper
• Identification of prokineticin‐2 as potential pharmacodynamic biomarker for overcoming doxorubicin resistance in multicellular breast cancer spheroids

  2025cites this paper
• Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment

  2024cites this paper
• Interaction of pregnane X receptor with hypoxia-inducible factor-1 regulates chemoresistance of prostate cancer cells

  2023cites this paper
• Zinc-enriched nanosystem for dual glycolysis regulation and photothermal therapy to synergistically inhibit primary melanoma and lung metastasis

  2022cites this paper
• A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies

  2021cites this paper
• Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.

  2020cites this paper
• Hypoxia-mediated drug resistance in breast cancers.

  2020cites this paper
• Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells.

  2020cites this paper
• Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate

  2020cites this paper
• Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy

  2019cites this paper
• Hypoxia in Tumor Microenvironment and Chemotherapy Resistance

  2018cites this paper
• Identification of novel regulators of HIFs for use in anti-cancer target development

  2018cites this paper
• Plasminogen/thrombomodulin signaling enhances VEGF expression to promote cutaneous wound healing

  2018cites this paper
• Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells

  2018cites this paper
• Methotrexate induced cell death mechanisms in MCF-7 adenocarcinoma breast cancer cells: Enhanced cytotoxicity following dff45-siRNA pre-treatment

  2018cites this paper
• Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells

  2017cites this paper
• Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance

  2017cites this paper
• The role of glucuronidation in drug resistance.

  2016cites this paper
• Suppression of ERK1/2 and hypoxia pathways by four Phyllanthus species inhibits metastasis of human breast cancer cells

  2016cites this paper
• Reprogramming the Transcriptional Response to Hypoxia with a Chromosomally Encoded Cyclic Peptide HIF-1 Inhibitor

  2016cites this paper
• [Glucuronidation of antitumour therapeutics--detoxification, mechanism of resistance or prodrug formation?].

  2015cites this paper
• The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis

  2015cites this paper
• Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.

  2015cites this paper
• Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.

  2015cites this paper
• Expression and significance of HIF-1α and Glut-1 in basal-like breast carcinoma

  2015cites this paper
• Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1α

  2014cites this paper
• Molecular aspects of the Warburg effect

  2014cites this paper
• Molecular mechanisms and physiology of disease

  2014cites this paper
• Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis.

  2014cites this paper
• HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

  2014cites this paper
• Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.

  2014cites this paper
• Hypoxia-regulated gene network in drug resistance and cancer progression

  2014cites this paper
• Immunosuppression may exert a hypoxia-mediated carcinogenetic effect in long-standing fistulizing Crohn's disease.

  2014cites this paper
• Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells.

  2014cites this paper
• CCKNOW and the dilemma of patient knowledge in inflammatory bowel disease.

  2014cites this paper
• HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia

  2013cites this paper
• Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.

  2013cites this paper
• Prognostic and predictive biomarkers for hypoxic regions on breast cancer: advances and challenges

  2013cites this paper
• Induction, modulation and potential targets of miR-210 in pancreatic cancer cells.

  2012cites this paper
• HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

  2012cites this paper
• Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells.

  2012cites this paper
• Molecular and Cellular Pathobiology Myc Posttranscriptionally Induces HIF 1 Protein and Target Gene Expression in Normal and Cancer Cells

  2012cites this paper
• Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis

  2012cites this paper
• Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.

  2011cites this paper
• Myc post-transcriptionally induces HIF 1 protein and target gene expression in normal and cancer cells

  2011cites this paper
• UDP-glucuronosyltransferase 1A6 overexpression in breast cancer cells resistant to methotrexate.

  2011cites this paper
• Glucose Metabolism in Breast Cancer and its Implication in Cancer Therapy

  2011cites this paper
• Hydroxyalkylbenzyle-pyrazoles et leur utilisation pour le traitement de maladies hyperprolifératives et angiogéniques

  2011cites this paper
• Rôle des protéines de choc thermique dans la régulation du facteur de transcription HIF

  2011cites this paper
• NANOG Has a Role in Mesenchymal Stem Cells' Immunomodulatory Effect

  2011cites this paper
• Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor α and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts

  2010cites this paper
• Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway

  2010cites this paper
• Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia

  2010cites this paper
• ERK/MAPK activation involves hypoxia‐induced MGr1‐Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer

  2010cites this paper
• Tumorigenesis and Neoplastic Progression Hypoxia Inducible Factor-1 Inactivation Unveils a Link between Tumor Cell Metabolism and Hypoxia-Induced Cell Death

  2010cites this paper
• Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy

  2010influential citation
• Chloroacétaldéhyde : de l’implication dans les mécanismes physiopathologiques de la néphrotoxicité de l’ifosfamide à la contribution à son effet anticancéreux

  2009cites this paper
• In Vitro Effects of Hypoxia-Inducible Factor 1&agr; on the Biological Characteristics of the SiHa Uterine Cervix Cancer Cell Line

  2009cites this paper
• Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1

  2009cites this paper
• Increased Transglutaminase 2 and GLUT-1 Expression in Breast Tumors not Susceptible to Chemoprevention with Antioxidants

  2009cites this paper
• Correlation between the expression of aquaporin 1 and hypoxia-inducible factor 1 in breast cancer tissues

  2008cites this paper
• Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR‐75

  2008cites this paper
• HIF-1α-deficient mouse embryonic fibroblasts

  2008cites this paper
• Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung

  2008cites this paper
• Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts.

  2008cites this paper
• New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells.

  2008cites this paper
• Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells

  2008cites this paper
• Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.

  2008cites this paper
• Review Hypoxia-inducible factor (HIF) in human tumorigenesis

  2007cites this paper
• Tumor growth and hypoxia: it's all about location, location and location

  2007cites this paper
• Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung.

  2007cites this paper
• Hypoxia-inducible factor (HIF) in human tumorigenesis.

  2007cites this paper
• Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis

  2007cites this paper
• Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

  2007cites this paper
• Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning.

  2007cites this paper
• Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injury.

  2007cites this paper
• Hypoxia‐inducible factor‐1α contributes to hypoxia‐induced chemoresistance in gastric cancer

  2007cites this paper
• The role of hypoxia inducible factor-1 in cell metabolism – a possible target in cancer therapy

  2006cites this paper
• Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years1

  2006cites this paper
• Open Access Research Article

  year unknowncites this paper
• Kobe University Repository : Kernel タイトル Tit le Comparison of 2 Dand 3 D-culture models as drug-test ing plat forms in breast cancer

  year unknowncites this paper